Biogen MS drug hit by EU safety restriction
July 10, 2017Regulators concerned over liver damage risk
X
Biogen MS drug hit by EU safety restriction
https://pharmaphorum.com/news/biogen-ms-drug-hit-eu-safety-restriction/
multiple sclerosis
Regulators finally back Merck KGaA oral MS drug
June 26, 2017
Brain infection would be bad news for Roche’s MS drug Ocrevus
May 30, 2017Suggestion is that PML case was caused by previous treatment.
Celgene MS pill can’t beat older rival on disability progression
May 24, 2017Phase 3 trial meets main efficacy endpoint, but disability progression stats cause concern.
Biogen shares up after strong launch for rare disease drug
April 26, 2017US insurers are covering the treatment, despite high price.
FDA approves two biggest new drugs of 2017
March 29, 2017Sales of MS and eczema drugs could top $4bn by 2022
Apitope aims to bounce back from MS setback
February 22, 2017Biotech looks for funding and long-term development partner
Celgene to file potential MS blockbuster this year
February 20, 2017Success with ozanimod would justify $7.2 billion outlay for Receptos.
